Dibenzylated polybenzimidazole based polymer and method for preparing the same
US-9509008-B2 · Nov 29, 2016 · US
US11299464B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11299464-B2 |
| Application number | US-201716321414-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 29, 2017 |
| Priority date | Jul 29, 2016 |
| Publication date | Apr 12, 2022 |
| Grant date | Apr 12, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are imidazolium polymers having steric hindrance at the 4-position of the imidazole moieties in the polymeric chain. The sterically-protected, N-methylated imidazolium polymers exhibit hydroxide stability in concentrated caustic solutions at elevated temperatures, such as at 100° C. and higher.
Opening claim text (preview).
The embodiments of the disclosure in which an exclusive property or privilege is claimed are defined as follows: 1. A polymer comprising a repeating unit of Formula (I): wherein: R 1 , R 2 , R 4 , and R 5 are each independently selected from absent, alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; provided that at least one of R 1 and R 2 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl, when one of R 1 and R 2 is absent, the imidazolyl group to which the absent R 1 or R 2 is connected is neutral; and at least one of R 4 and R 5 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; and when one of R 4 and R 5 is absent, the imidazolyl group to which the absent R 4 or R 5 is connected is neutral; R 3 and R 6 are each independently selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, aralkyl, and heteroaryl; R 15 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 16 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 7 , R 10 , R 11 , and R 14 are each independently selected from alkyl, perfluoroalkyl, and heteroalkyl; and R 8 , R 9 , R 12 , and R 13 are each independently selected from hydrogen, alkyl, perfluoroalkyl, and heteroalkyl. 2. The polymer of claim 1 , wherein the polymer comprises a repeating unit of Formula (I-A): wherein: R 1 , R 2 , R 4 , and R 5 are each independently selected from absent, alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; provided that at least one of R 1 and R 2 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl, when one of R 1 and R 2 is absent, the imidazolyl group to which the absent R 1 or R 2 is connected is neutral; at least one of R 4 and R 5 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; and when one of R 4 and R 5 is absent, the imidazolyl group to which the absent R 4 or R 5 is connected is neutral; R 3 and R 6 are each independently selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, aralkyl, and heteroaryl; R 15 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 16 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 7 , R 10 , R 11 , and R 14 are each independently selected from alkyl, perfluoroalkyl, and heteroalkyl; and R 8 , R 9 , R 12 , and R 13 are each independently selected from hydrogen, alkyl, perfluoroalkyl, and heteroalkyl. 3. The polymer of claim 1 , wherein the polymer comprises a repeating unit of Formula (I-B): wherein: R 1 , R 2 , R 4 , and R 5 are each independently selected from absent, alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; provided that at least one of R 1 and R 2 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl, when one of R 1 and R 2 is absent, the imidazolyl group to which the absent R 1 or R 2 is connected is neutral; and at least one of R 4 and R 5 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; and when one of R 4 and R 5 is absent, the imidazolyl group to which the absent R 4 or R 5 is connected is neutral; R 3 and R 6 are each independently selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, aralkyl, and heteroaryl; R 15 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 16 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 7 , R 10 , R 11 , and R 14 are each independently selected from alkyl, perfluoroalkyl, and heteroalkyl; and R 8 , R 9 , R 12 , and R 13 are each independently selected from hydrogen, alkyl, perfluoroalkyl, and heteroalkyl. 4. The polymer of claim 1 , wherein the polymer comprises a repeating unit of Formula (I-C): wherein: R 1 , R 2 , R 4 , and R 5 are each independently selected from absent, alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; provided that at least one of R 1 and R 2 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl, when one of R 1 and R 2 is absent, the imidazolyl group to which the absent R 1 and R 2 is connected is neutral; and at least one of R 4 and R 5 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; and when one of R 4 and R 5 is absent, the imidazolyl group to which the absent R 4 or R 5 is connected is neutral; R 3 and R 6 are each independently selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, aralkyl, and heteroaryl; R 15 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 16 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 7 , R 10 , R 11 , and R 14 are each independently selected from alkyl, perfluoroalkyl, and heteroalkyl; and R 8 , R 9 , R 12 , and R 13 are each independently selected from hydrogen, alkyl, perfluoroalkyl, and heteroalkyl. 5. The polymer of claim 1 , wherein the polymer comprises a repeating unit of Formula (I-D): wherein: R 1 , R 2 , R 4 , and R 5 are each independently selected from absent, alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; provided that at least one of R 1 and R 2 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl, when one of R 1 and R 2 is absent, the imidazolyl group to which the absent R 1 or R 2 is connected is neutral; and at least one of R 4 and R 5 is selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, and aralkyl; and when one of R 4 and R 5 is absent, the imidazolyl group to which the absent R 4 or R 5 is connected is neutral; R 3 and R 6 are each independently selected from alkyl, perfluoroalkyl, heteroalkyl, aryl, aralkyl, and heteroaryl; R 15 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 16 is arylene optionally substituted with 1, 2, 3, or 4 substituents independently selected from alkyl, perfluoroalkyl, heteroalkyl, and halo; R 7 , R 10 , R 11 , and R 14 are each independently selected from alkyl, perfluoroalkyl, and heteroalkyl; and R 8 , R 9 , R 12 , and R 13 are each independently selected from hydrogen, alkyl, perfluoroalkyl, and heteroalkyl. 6. The polymer of claim 1 , wherein R 1 , R 2 , R 4 , and R 5 are each independently selected from absent, methyl, and trifluoromethyl; provided that at least one of R 1 and R 2 is selected from methyl and trifluoromethyl; and at least one of R 4 and R 5
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title
with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine · CPC title
with only two nitrogen atoms in the ring · CPC title
Amines · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.